Search research articles
Contact Us
Filters
Showing results (1-10 of 121) with videos related to
Page
of 13
Sort By:
The British Journal of Dermatology
|
January 6, 2025
Postswitching discontinuation of biosimilars in psoriasis: registry analyses fall short in addressing real-world biases
Luis Puig
The Journal of Investigative Dermatology
|
August 5, 2025
Repurposing Roflumilast and the Emerging Landscape of Phosphodiesterase 4 Inhibition in Psoriasis
Luis Puig
Lancet (London, England)
|
September 21, 2025
Icotrokinra in psoriasis: IL-23 receptor antagonism via oral peptide with biologic-level efficacy
Luis Puig
American Journal of Clinical Dermatology
|
April 12, 2020
Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic
Tiago Torres, Luis Puig
American Journal of Clinical Dermatology
|
June 10, 2017
Apremilast: A Novel Oral Treatment for Psoriasis and Psoriatic Arthritis
Tiago Torres, Luis Puig
Dermatology and Therapy
|
August 8, 2025
Letter to the Editor Regarding: "Cardiovascular and Kidney Outcomes After Systemic Treatment for Plaque Psoriasis: A Systematic Review and Network Meta‑Analysis"
Tiago Torres, Luis Puig
International Journal of Molecular Sciences
|
February 25, 2023
Tyk2 Targeting in Immune-Mediated Inflammatory Diseases
Lluís Rusiñol, Luis Puig
American Journal of Clinical Dermatology
|
October 27, 2021
Authors' reply to Borg and Thoning: "Comment on: Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study"
Tiago Torres, Andrea Chiricozzi, Luis Puig
Current Treatment Options in Oncology
|
May 1, 2020
The Role of Epithelial-to-Mesenchymal Transition in Cutaneous Squamous Cell Carcinoma : Epithelial-to-Mesenchymal Transition in Cutaneous SCC
Maria-Teresa Fernandez-Figueras, Luis Puig
Drugs
|
February 6, 2020
JAK Inhibitors for Treatment of Psoriasis: Focus on Selective TYK2 Inhibitors
Miguel Nogueira, Luis Puig, Tiago Torres
Page
of 13
Search research articles
Search
Showing results (1-10 of 121) with videos related to
Sort By:
Page
of 13
The British Journal of Dermatology
|
January 6, 2025
Postswitching discontinuation of biosimilars in psoriasis: registry analyses fall short in addressing real-world biases
Luis Puig
The Journal of Investigative Dermatology
|
August 5, 2025
Repurposing Roflumilast and the Emerging Landscape of Phosphodiesterase 4 Inhibition in Psoriasis
Luis Puig
Lancet (London, England)
|
September 21, 2025
Icotrokinra in psoriasis: IL-23 receptor antagonism via oral peptide with biologic-level efficacy
Luis Puig
American Journal of Clinical Dermatology
|
April 12, 2020
Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic
Tiago Torres, Luis Puig
American Journal of Clinical Dermatology
|
June 10, 2017
Apremilast: A Novel Oral Treatment for Psoriasis and Psoriatic Arthritis
Tiago Torres, Luis Puig
Dermatology and Therapy
|
August 8, 2025
Letter to the Editor Regarding: "Cardiovascular and Kidney Outcomes After Systemic Treatment for Plaque Psoriasis: A Systematic Review and Network Meta‑Analysis"
Tiago Torres, Luis Puig
International Journal of Molecular Sciences
|
February 25, 2023
Tyk2 Targeting in Immune-Mediated Inflammatory Diseases
Lluís Rusiñol, Luis Puig
American Journal of Clinical Dermatology
|
October 27, 2021
Authors' reply to Borg and Thoning: "Comment on: Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study"
Tiago Torres, Andrea Chiricozzi, Luis Puig
Current Treatment Options in Oncology
|
May 1, 2020
The Role of Epithelial-to-Mesenchymal Transition in Cutaneous Squamous Cell Carcinoma : Epithelial-to-Mesenchymal Transition in Cutaneous SCC
Maria-Teresa Fernandez-Figueras, Luis Puig
Drugs
|
February 6, 2020
JAK Inhibitors for Treatment of Psoriasis: Focus on Selective TYK2 Inhibitors
Miguel Nogueira, Luis Puig, Tiago Torres
Page
of 13